These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3892385)

  • 1. Limitations of drug sensitivity testing in soft agar for clinical management of patients with ovarian carcinoma.
    Arbuck SG; Pavelic ZP; Piver MS; Slocum HK; Malfetano J; Gamarra M; Rustum YM
    Obstet Gynecol; 1985 Jul; 66(1):115-20. PubMed ID: 3892385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy testing for human ovarian cancer using in vitro colony assay].
    Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the tumor colony assay in therapy planning in malignant ovarian tumors].
    Schieder K; Kölbl H; Bieglmayer C
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):41-4. PubMed ID: 3569826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemosensitivity testing for human ovarian cancer on in vitro colony assay].
    Inoue K
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1146-51. PubMed ID: 6471421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pretherapeutic chemosensitivity testing of ovarian cancer and possibilities for its clinical use].
    Hernádi Z; Pásti G; Lampé L; Juhász B
    Zentralbl Gynakol; 1985; 107(17):1065-71. PubMed ID: 4060913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro chemosensitivity of urological malignancies evaluated by colony-forming assay using soft agar].
    Yamamoto N
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1573-81. PubMed ID: 4040734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
    Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further experience in testing the sensitivity of human ovarian carcinoma cells to interferon in an in vitro semisolid agar culture system: comparison of solid and ascitic forms of the tumor.
    Epstein LB; Shen JT; Abele JS; Reese CC
    Prog Clin Biol Res; 1980; 48():277-90. PubMed ID: 6163159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a human tumor colony-forming assay to new drug screening.
    Shoemaker RH; Wolpert-DeFilippes MK; Kern DH; Lieber MM; Makuch RW; Melnick NR; Miller WT; Salmon SE; Simon RM; Venditti JM
    Cancer Res; 1985 May; 45(5):2145-53. PubMed ID: 3986767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervix.
    Parker RL; Welander CE; Homesley HD; Jobson VW; Kawamoto EH
    Obstet Gynecol; 1984 Sep; 64(3):412-6. PubMed ID: 6462571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.
    Ng TY; Ngan HY; Cheng DK; Wong LC
    Gynecol Oncol; 2000 Mar; 76(3):405-8. PubMed ID: 10684718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy sensitivity of gynecologic malignancies determined by the human tumor stem cell assay (HTSCA)].
    Obi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):792-8. PubMed ID: 3598274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colony assay for clinical application].
    Ichihashi H; Sako T; Akiyama S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1560-5. PubMed ID: 3927845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
    Orr JW; Orr P; Kern DH
    Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticancer drug sensitivity tested by tumor stem cell assay].
    Hiraki S; Ohnoshi T; Miyai M; Numata T; Kishimoto N; Miyamoto H; Kimura I
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1139-45. PubMed ID: 6471420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human tumor stem cell assay revisited.
    Singletary SE; Umbach GE; Spitzer G; Drewinko B; Tomasovic B; Ajani J; Hug V; Blumenschein G
    Int J Cell Cloning; 1985 Mar; 3(2):116-28. PubMed ID: 3998518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.